Literature DB >> 34723629

Highly Conserved gsc1 Gene of Pneumocystis jirovecii in Patients with or without Prior Exposure to Echinocandins.

Pierre L Bonnet1,2, Solène Le Gal1,2, Claire V Hoffmann1,2, Florent Morio3,4, Fouleymata Diabira2, Athéna de Quélen2, Guillaume Curral2, Steven Negri2, Virginie Cogulet5, Jean-François Huon6, Matthieu Grégoire7, Nicolas Papon2, Patrice Le Pape3,4, Jean-Philippe Bouchara2, Gilles Nevez1,2.   

Abstract

Echinocandins are noncompetitive inhibitors of the GSC1 subunit of the enzymatic complex involved in synthesis of 1,3-beta-d-glucan, a cell wall component of most fungi, including Pneumocystis spp. Echinocandins are widely used for treating systemic candidiasis and rarely used for treating Pneumocystis pneumonia. Consequently, data on P. jirovecii gsc1 gene diversity are still scarce compared to that for the homologous fks1 gene of Candida spp. In this study, we analyzed P. jirovecii gsc1 gene diversity and the putative selection pressure of echinocandins on P. jirovecii. gsc1 gene sequences of P. jirovecii specimens from two patient groups were compared. One group of 27 patients had prior exposure to echinocandins, whereas the second group of 24 patients did not, at the time of P. jirovecii infection diagnoses. Two portions of the P. jirovecii gsc1 gene, HS1 and HS2, homologous to hot spots described in Candida spp., were sequenced. Three single-nucleotide polymorphisms (SNPs) at positions 2204, 2243, and 2303 close to the HS1 region and another SNP at position 4540 more distant from the HS2 region were identified. These SNPs represent synonymous mutations. Three gsc1 HS1 alleles, A, B, and C, and two gsc1 HS2 alleles, a and b, and four haplotypes, Ca, Cb, Aa, and Ba, were defined, without significant difference in haplotype distribution in both patient groups (P = 0.57). Considering the identical diversity of P. jirovecii gsc1 gene and the detection of synonymous mutations in both patient groups, no selection pressure of echinocandins among P. jirovecii microorganisms can be pointed out so far.

Entities:  

Keywords:  1,3-beta-d-glucan; Pneumocystis jirovecii; echinocandins; genomic diversity; gsc1; hot spots

Mesh:

Substances:

Year:  2021        PMID: 34723629      PMCID: PMC8765322          DOI: 10.1128/AAC.01563-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  35 in total

1.  Real time quantitative PCR assay for Pneumocystis jirovecii detection.

Authors:  Leila Meliani; Michel Develoux; Marie Marteau-Miltgen; Denis Magne; Veronique Barbu; Jean-Louis Poirot; Patricia Roux
Journal:  J Eukaryot Microbiol       Date:  2003       Impact factor: 3.346

2.  Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.

Authors:  Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas F Patterson; David W Denning; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2004-11-09       Impact factor: 9.079

3.  Experiment files and their application during large-scale sequencing projects.

Authors:  J K Bonfield; R Staden
Journal:  DNA Seq       Date:  1996

4.  A proposal for pragmatic investigation of possible clonal clusters of pneumocystis pneumonia cases.

Authors:  G Nevez; F Morio; P Bonnet; N Le Nan; F-X Blanc; S Le Gal
Journal:  J Hosp Infect       Date:  2020-11-30       Impact factor: 3.926

5.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

6.  A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii.

Authors:  Solène Le Gal; Céline Damiani; Amélie Rouillé; Anne Grall; Laetitia Tréguer; Michèle Virmaux; Elodie Moalic; Dorothée Quinio; Marie-Christine Moal; Christian Berthou; Philippe Saliou; Yann Le Meur; Anne Totet; Gilles Nevez
Journal:  Clin Infect Dis       Date:  2012-02-14       Impact factor: 9.079

7.  Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene.

Authors:  Anne Totet; Leila Meliani; Philippe Lacube; Jean Claude Pautard; Christian Raccurt; Patricia Roux; Gilles Nevez
Journal:  J Eukaryot Microbiol       Date:  2003       Impact factor: 3.346

8.  Trimethoprim resistance of dihydrofolate reductase variants from clinical isolates of Pneumocystis jirovecii.

Authors:  S F Queener; V Cody; J Pace; P Torkelson; A Gangjee
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

9.  Site-Directed Mutagenesis of the 1,3-β-Glucan Synthase Catalytic Subunit of Pneumocystis jirovecii and Susceptibility Assays Suggest Its Sensitivity to Caspofungin.

Authors:  A Luraschi; S Richard; P M Hauser
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.

Authors:  Gwénolé Prigent; Nawel Aït-Ammar; Eric Levesque; Arnaud Fekkar; Jean-Marc Costa; Sarra El Anbassi; Françoise Foulet; Christophe Duvoux; Jean-Claude Merle; Eric Dannaoui; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.